Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTAW) Return on Equity (2020 - 2025)

Historic Return on Equity for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to 0.16%.

  • Strata Critical Medical's Return on Equity rose 3600.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year increase of 3600.0%. This contributed to the annual value of 0.12% for FY2024, which is 1000.0% up from last year.
  • As of Q3 2025, Strata Critical Medical's Return on Equity stood at 0.16%, which was up 3600.0% from 0.1% recorded in Q2 2025.
  • Strata Critical Medical's 5-year Return on Equity high stood at 0.16% for Q3 2025, and its period low was 0.23% during Q4 2023.
  • For the 5-year period, Strata Critical Medical's Return on Equity averaged around 0.11%, with its median value being 0.1% (2025).
  • As far as peak fluctuations go, Strata Critical Medical's Return on Equity crashed by -10400bps in 2021, and later skyrocketed by 3600bps in 2025.
  • Quarter analysis of 5 years shows Strata Critical Medical's Return on Equity stood at 0.06% in 2021, then plummeted by -65bps to 0.1% in 2022, then crashed by -131bps to 0.23% in 2023, then skyrocketed by 41bps to 0.13% in 2024, then surged by 222bps to 0.16% in 2025.
  • Its last three reported values are 0.16% in Q3 2025, 0.1% for Q2 2025, and 0.13% during Q1 2025.